(PRWEB) April 18, 2013
The US Drug Watchdog is now offering to help all US women, who are victim's of a severe transvaginal mesh failure get to the best possible attorneys, and the group is promising the attorneys will all be women, if the failure involves erosion, or a failed revision surgery to repair the transvaginal mesh product. According to court records transvaginal mesh products were designed for women, who were suffering from pelvic organ prolapse, and or stress urinary incontinence. According to the US FDA the procedure to install a transvaginal was supposed to be minimally-invasive. The FDA is now saying transvaginal mesh failures is causing complications in patients such as erosion and infection. Women who experience transvaginal mesh failure may need to have numerous corrective surgeries, IV therapy, blood transfusions and drainage of hematomas or abscesses. They also may develop a condition called erosion where the mesh protrudes through the vaginal wall." The US Drug Watchdog is now expanding their national initiative designed to help women recipients of a transvaginal mesh medical product, who are now severely injured with erosion, or other severe medical complications associated with this type of product. For more information women, who are victims of a transvaginal mesh failure are urged to contact the US Drug Watchdog anytime at 866-714-6466.
The US Drug Watchdog is indicating symptoms of a transvaginal mesh implants may include:
U.S. District Court for the Southern District of West Virginia Multidistrict litigation (MDL) consolidates all similar cases into one courtroom and will include the Defendants:
C.R. Bard, Inc., (MDL No. 2187);
American Medical Systems Inc., MDL No. 2325);
Boston Scientific Corp., (MDL No. 2326); and Johnson & Johnson's Ethicon, Inc. (MDL No. 2327)
Read the full story at http://www.prweb.com/releases/2013/4/prweb10621377.htm.
Copyright©2012 Vocus, Inc.
All rights reserved